{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:32:20Z","timestamp":1787070740755,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sepsis remains a leading cause of mortality in intensive care units (ICUs) worldwide, necessitating improved diagnostic and prognostic tools. This study aimed to estimate the novel sepsis biomarkers, including presepsin, interleukin (IL)-27, hepcidin, and plasma chitotriosidase in ICU patients with sepsis, evaluating their potential for enhancing early diagnosis and monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective study was conducted over 18 months at JSS Medical College and Hospital, Mysuru, India. The study included 73 ICU patients above 18 years diagnosed with bacterial sepsis based on Quick Sequential Organ Failure Assessment score and procalcitonin (PCT) levels. Blood samples were collected and analyzed using enzyme-linked immunosorbent assay with respective biomarker kits. Demographic data, clinical parameters, and laboratory values were recorded. Correlations between novel biomarkers and PCT were assessed using Pearson correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study population had a mean age of 55.7 years, with 60.3% male participants. Hypertension (56.16%) and type 2 diabetes mellitus (49.32%) were the most common comorbidities. Abnormal presepsin levels were observed in 53.4% of participants, showing a strong positive correlation with PCT (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.763,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Hepcidin levels were abnormal in 76.7% of participants, demonstrating a moderate positive correlation with PCT (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.522,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Only 11.0% of participants had abnormal IL-27 levels, with a weak, nonsignificant correlation with PCT (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.172,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.540). All participants (100%) had abnormal chitotriosidase levels, showing a weak but significant positive correlation with PCT (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.234,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.047).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study supports the potential of presepsin and hepcidin as novel biomarkers for sepsis in ICU patients. These markers showed strong correlations with PCT and high rates of abnormal levels in sepsis patients. IL-27 and chitotriosidase showed less promise in our study population. Integrating these novel biomarkers, particularly presepsin and hepcidin, into clinical practice could potentially improve early diagnosis and management of sepsis in critical care settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_1_25","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:00:09Z","timestamp":1751284809000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Study of Novel Sepsis Biomarkers Presepsin, Interleukin-27, Hepcidin, Plasma Chitotriosidase in Intensive Care Unit Patients with Sepsis and Correlation with Serum Procalcitonin Levels"],"prefix":"10.4103","volume":"25","author":[{"given":"K. C.","family":"Shashidhara","sequence":"first","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karnati Prudhveer","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ashok","sequence":"additional","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119835043","article-title":"Sepsis: The evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali","year":"2019","journal-title":"SAGE Open Med"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5152\/TJAR.2017.93753","article-title":"Changing definitions of sepsis","volume":"45","author":"G\u00fcl","year":"2017","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"628302","DOI":"10.3389\/fmed.2021.628302","article-title":"Sepsis-pathophysiology and therapeutic concepts","volume":"8","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11908-021-00765-y","article-title":"Diagnostic challenges in sepsis","volume":"23","author":"Duncan","year":"2021","journal-title":"Curr Infect Dis Rep"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.3390\/jcm11195782","article-title":"Biomarkers for the prediction and judgement of sepsis and sepsis complications: A step towards precision medicine?","volume":"11","author":"von","year":"2022","journal-title":"J Clin Med"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/CMR.00016-12","article-title":"New approaches to sepsis: Molecular diagnostics and biomarkers","volume":"25","author":"Reinhart","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1586\/1744666X.2014.949675","article-title":"Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment","volume":"10","author":"Sandquist","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2020.52.1.1","article-title":"An update on sepsis biomarkers","volume":"52","author":"Kim","year":"2020","journal-title":"Infect Chemother"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s10156-011-0254-x","article-title":"Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome","volume":"17","author":"Shozushima","year":"2011","journal-title":"J Infect Chemother"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10156-012-0435-2","article-title":"Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study","volume":"18","author":"Endo","year":"2012","journal-title":"J Infect Chemother"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1442-200X.2008.02688.x","article-title":"Serum pro-hepcidin levels in term and preterm newborns with sepsis","volume":"51","author":"Yapak\u00e7i","year":"2009","journal-title":"Pediatr Int"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"ofy313","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: Worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s00134-020-06106-2","article-title":"Epidemiology and burden of sepsis acquired in hospitals and intensive care units: A systematic review and meta-analysis","volume":"46","author":"Markwart","year":"2020","journal-title":"Intensive Care Med"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/ijms18091932","article-title":"The effect of sepsis on the erythrocyte","volume":"18","author":"Bateman","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2010.851","article-title":"Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis","volume":"303","author":"Mayr","year":"2010","journal-title":"JAMA"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: A multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0972-5229.126077","article-title":"Hyponatremia in critically ill patients","volume":"18","author":"Padhi","year":"2014","journal-title":"Indian J Crit Care Med"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5847\/wjem.j.issn.1920-8642.2014.01.002","article-title":"Presepsin as a novel sepsis biomarker","volume":"5","author":"Zou","year":"2014","journal-title":"World J Emerg Med"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"14857","DOI":"10.1038\/s41598-022-18826-0","article-title":"Hepcidin discriminates sepsis from other critical illness at admission to intensive care","volume":"12","author":"Olinder","year":"2022","journal-title":"Sci Rep"},{"key":"R25-20260109","first-page":"652","article-title":"Value of hepcidin as a diagnostic biomarker of sepsis in critically ill adults","volume":"30","author":"Qiu","year":"2018","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/cc11847","article-title":"Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children","volume":"16","author":"Wong","year":"2012","journal-title":"Crit Care"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13054-015-1095-2","article-title":"Interleukin-27: A novel biomarker in predicting bacterial infection among the critically ill","volume":"19","author":"Hanna","year":"2015","journal-title":"Crit Care"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_1_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:48Z","timestamp":1787067348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_1_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_1_25","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"2025-01-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}